107 results
P
patients with severe aortic stenosis
I/C
transcatheter heart valve (THV) systems: balloon-expandable (BE) and self-expandable (SE), surgical aortic valve replacement (SAVR), BE-THV vs. SE-THV, BE-THV vs. SAVR, SE-THV vs. SAVR
O
durability of THV systems and surgical aortic valve replacement prosthesis, echocardiographic outcomes, clinical outcomes, structural valve deterioration (SVD), total moderate-severe aortic regurgitation and reintervention
P
patients with failed surgical bioprostheses
I/C
self-expanding (SE) or balloon-expandable (BE) valves, SE vs BE transcatheter heart valves
O
all-cause mortality at 12 months
P
insomnia
I/C
orexin receptor antagonists (ORAs), benzodiazepine-like drugs (Z-drugs), melatonin receptor agonists (MRAs), placebo
O
sleep latency (SL), awake time after sleep onset (WASO), total sleep time (TST), sleep efficiency (SE), sleep quality (SQ), adverse events (AED)
P
insomnia
I/C
cognitive behavior therapy for insomnia (CBT-I), pharmacotherapy, each other, alone
O
subjective sleep efficiency (SE), subjective wake time after sleep onset (WASO), insomnia severity index (ISI) score, sleep parameters
P
adults with insomnia
I/C
web-based CBTi with a therapist, usual care
O
self-reported total sleep time (TST), sleep onset latency (SOL), wake after sleep onset (WASO), sleep efficiency (SE)
P
Oral anticoagulants (OAC), P-glycoprotein (P-gp)/CYP3A4 enzyme
I/C
P-gp/CYP3A4 inhibitors, Rivaroxaban, Dabigatran, Apixaban, Edoxaban, Warfarin
O
Major bleeding, Gastrointestinal (GI) bleeding, Stroke/systemic embolism (SE), All-cause mortality, Any bleeding, Intracranial hemorrhage (ICH)
P
functional constipation (FC)
I/C
acupuncture, sham acupuncture
O
complete spontaneous bowel movement (CSBM), spontaneous bowel movement, Bristol Stool Form Scale (BSFS), responder rate, safety evaluation (SE)
P
selenium
I/C
inductively coupled plasma mass spectrometry, hydrolysis methodology
O
optimal recovery values
P
COVID-19 patients
I/C
Tocilizumab, Sarilumab, No treatment
O
Mortality